J&A_for_posting_Redacted.pdf

This document provides details on a federal contract opportunity for the supply of Japanese Encephalitis Vaccine. The Defense Logistics Agency Troop Support is seeking to award a one-year firm-fixed price indefinite quantity contract for the supply of between 420,000 and 500,000 doses of Japanese Encephalitis Vaccine per year. The vaccine must be purified, inactivated, Vero Cell culture derived, free of stabilizers, thimerosal, preservatives, and latex. It must be licensed by the FDA, suitable for intramuscular administration, and intended for active immunization against Japanese Encephalitis for persons 2 months and older. Doses are to be delivered to the Defense Distribution Depot Susquehanna within 120 days of order placement. The solicitation SPE2DP-18-R-0111 is expected to issue in June 2018 and will be posted on the DLA Internet Bid Board System. The point of contact for the opportunity is Danielle Delaney of the DLA Troop Support-FSA. The justification cited for the award is that the vaccine has only one responsible source as defined by 10 U.S.C. 2034 (c) 1.